Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients (Breast Cancer Research and Treatment, (2017), 165, 2, (343-353), 10.1007/s10549-017-4328-z)

On Behalf Of The IrisTrial Participants

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients (Breast Cancer Research and Treatment, (2017), 165, 2, (343-353), 10.1007/s10549-017-4328-z)'. Together they form a unique fingerprint.

Medicine & Life Sciences